NicoleLugo SantiagoMD(She/Her)

Gynecologic Oncology

Gynecologic Oncology Research Fellow

Dr. Lugo Santiago is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
735 Ave Ponce de Leon
Suite 812 Torre Medica Auxilio Mutuo
San Juan, PR 00917
Phone+1 866-600-2273

City of Hope National Medical CenterFellowship, Gynecologic Oncology, 2021 - 2024
University of Illinois College of Medicine at ChicagoResidency, Obstetrics and Gynecology, 2017 - 2021
Universidad de Puerto RicoBachelor in Science, Cell and Molecular Biology, Magna Cum Laude, 2009 - 2013
University of Michigan Medical SchoolClass of 2013

PubMed

2 citations
Niraparib-induced STAT3 inhibition increases its antitumor effects.
Qianqian Zhao, Adrian Kohut, Yi-Jia Li, Antons Martincuks, Theresa Austria
Frontiers in Oncology. 2022-01-01

Journal Articles

Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation
Nicole Lugo Santiago 1, Evan Smith, Mary Cox, Carrie S Wan, Nana E Tchabo, Ibraheem Awowole, Vance Broach, Dennis S Chi, Obstetrics & Gynecology, 6/2020
Management and survival of patients with Mullerian adenosarcoma of the cervix without sarcomatous overgrowth desiring fertility preservation, a case report and review ...
Nicole Lugo Santiago 1, John Groth 1, Nuzhath Hussain 1, Rajul Kothari 1, Gynecologic Oncology Reports, 12/2019